We’re attending CIPA’s 2021 Life Sciences Conference

No items found.
​
30 October 2021
Tags
No items found.
Table of contents
  • Toc Heading
  • Toc Heading

Our Life and HealthTech Practice Groups will attend CIPA’s Life Sciences Conference on the 29 November.

The conference is the UK’s preeminent life sciences event which will provide the opportunity for patent and IP professionals active in the pharma, medical technology and biotechnology sectors to connect and discuss trending topics.

As in previous years, Partner and Head of EIP HealthTech, Gareth Probert will be giving the conference’s annual update on EP case law. He will be highlighting the significant cases and practice changes which will impact how life science companies obtain and challenge patents at the EPO.

EIP Partners, Monika Rai, Andrew Sharples and Darren Smyth will also be in attendance.

If you are interested in meeting us at the event, please email us.

Visit CIPA’s website to find out more about the event.

Related articles

See all articles

EIP recognsied for strategic leadership in patent law at the Professional Services Management Excellence Awards
26 March 2026
EIP has been recognised with two Professional Services Management Excellence Awards 2026, including Excellence in Strategic Leadership and Best in Theme: Leadership. The awards reflect the firm’s commitment to aligning patent expertise with commercial insight, strengthening leadership across the firm and delivering patent strategy that supports investment, growth and high‑value business decisions.
​
EIP promotes Callum Docherty to Principal in the US
19 March 2026
EIP is pleased to announce the promotion of Callum Docherty to Principal, recognizing his substantial contribution to the firm’s international patent practice and his leadership within EIP’s growing US team.
​
EIP announces the promotion of Rob Barker to Partner
12 March 2026
EIP is pleased to announce the promotion of Robert Barker to Partner, recognising his significant contribution to the firm’s Digital, Chemistry, Life Sciences, and multidisciplinary patent practice since joining in 2014.
​